NeurologyLive® Mind Moments®

155: Understanding Variability in Infantile Spasms Care


Listen Later

Welcome to the NeurologyLive® Mind Moments® podcast. Tune in to hear leaders in neurology sound off on topics that impact your clinical practice.

In this episode, "Understanding Variability in Infantile Spasms Care," Christina Briscoe, MD, epileptologist at Boston Children’s Hospital, discusses new multi-center findings on current treatment practices for infantile epileptic spasms syndrome (IESS). Briscoe outlines why first- and second-line therapies remain largely standardized, yet significant variability emerges once hormonal therapy and vigabatrin fail. She details the evidence gaps driving inconsistent third-line and fourth-line decision-making, including limited clinical trial data, uneven access to ketogenic diet programs and epilepsy surgery, and historically low industry investment in infant-specific trials. Additional discussion focuses on ongoing research from the Pediatric Epilepsy Research Consortium, national and global comparisons in treatment pathways, barriers to study scalability in rare pediatric epilepsies, and the practical challenges of implementing timely diagnosis and standardized care across diverse healthcare settings. Briscoe also highlights under-recognized issues such as incorporation of ketogenic diet and early surgical evaluation into treatment pathways, and emphasizes the need for broader infrastructure, funding, and multi-center collaboration to improve outcomes for children with IESS.

Looking for more Epilepsy discussion? Check out the NeurologyLive® Epilepsy clinical focus page.

Episode Breakdown:
  • 1:05 – Origins of the study, need to pursue more standardized care in IESS
  • 4:40 – Reasons behind treatment variability after first and second-line options
  • 8:00 – What research is needed to guide sequencing and standardize care
  • 12:05 – Neurology News Minute
  • 14:30 – What makes IESS studies difficult and how infrastructure can improve
  • 18:50 – Lesser-discussed gaps, including ketogenic diet and surgical evaluation

    The stories featured in this week's Neurology News Minute, which will give you quick updates on the following developments in neurology, are further detailed here:

    • Positive Phase 3 OCEANIC-STROKE Data Position Asundexian for Upcoming FDA Submission
    • FDA Approves New Intrathecal Administration Route for Spinal Muscular Atrophy Gene Therapy
    • GLP-1 Semaglutide Fails to Outperform Placebo in Phase 3 EVOKE Trial of Alzheimer Disease

    • Thanks for listening to the NeurologyLive® Mind Moments® podcast. To support the show, be sure to rate, review, and subscribe wherever you listen to podcasts. For more neurology news and expert-driven content, visit neurologylive.com.
      ...more
      View all episodesView all episodes
      Download on the App Store

      NeurologyLive® Mind Moments®By NeurologyLive

      • 4.6
      • 4.6
      • 4.6
      • 4.6
      • 4.6

      4.6

      10 ratings


      More shows like NeurologyLive® Mind Moments®

      View all
      NEJM This Week by NEJM Group

      NEJM This Week

      317 Listeners

      Neurology® Podcast by American Academy of Neurology

      Neurology® Podcast

      296 Listeners

      Practical Neurology Podcast by BMJ Group

      Practical Neurology Podcast

      50 Listeners

      The Clark Howard Podcast by Clark Howard

      The Clark Howard Podcast

      5,454 Listeners

      JAMA Neurology Author Interviews by JAMA Network

      JAMA Neurology Author Interviews

      12 Listeners

      BMJ Best Practice Podcast by BMJ Group

      BMJ Best Practice Podcast

      20 Listeners

      Neurology Today in 5 by American Academy of Neurology

      Neurology Today in 5

      23 Listeners

      Neurology Minute by American Academy of Neurology

      Neurology Minute

      133 Listeners

      Dateline NBC by NBC News

      Dateline NBC

      47,546 Listeners

      The Ezra Klein Show by New York Times Opinion

      The Ezra Klein Show

      15,833 Listeners

      Movers and Shakers: a podcast about life with Parkinson's by Podot

      Movers and Shakers: a podcast about life with Parkinson's

      108 Listeners

      Continuum Audio by American Academy of Neurology

      Continuum Audio

      81 Listeners

      Chanticleer by Australian Financial Review

      Chanticleer

      17 Listeners

      The Top Line by Fierce Life Sciences

      The Top Line

      12 Listeners

      The Economics Show by Financial Times

      The Economics Show

      143 Listeners